Related Experiment Videos
Alterations in human lung parenchyma after cytostatic therapy
1Department of Pathology, Thoraxklinik, Heidelberg, FRG.
Summary
Long-term chemotherapy can cause lung damage, including focal interstitial fibrosis in nearly half of patients. These changes, potentially due to inflammation or toxicity, show similarities to alterations seen in tuberculosis.
Area of Science:
- Pulmonary Pathology
- Oncology
- Immunohistochemistry
Background:
- Chemotherapy targets tumor cells but can also affect normal organs.
- Lung parenchyma alterations following cytostatic therapy require detailed morphologic assessment.
Purpose of the Study:
- To evaluate morphologic changes in tumor-free lung tissue after long-term cytostatic therapy.
- To compare chemotherapy-induced lung changes with those in tuberculosis and sarcoidosis.
Main Methods:
- Morphologic analysis of 63 lung metastasis surgical specimens from patients treated with cytostatic therapy.
- Histological staining (HE, PAS, Sirius) and immunohistochemistry (neoglycoproteins, HLA-DR antibody).
- Comparison with 20 untreated patients, 18 tuberculosis cases, and 37 sarcoidosis cases.
Main Results:
- Focal interstitial fibrosis observed in 44% of chemotherapy patients vs. 10% of controls.
- Dysplastic pneumocytes found in 16% of treated patients; HLA-DR expression in 43% of treated patients.
- Similarities in fucose and lactose receptor expression between chemotherapy and tuberculosis cohorts.
Conclusions:
- Long-lasting cytostatic therapy induces focal fibrosis in 40%-50% of patients, primarily through interstitial inflammatory infiltrates.
- Pathologic alterations may result from hypersensitivity reactions or direct toxicity.
- Chemotherapy-induced lung changes share some characteristics with tuberculosis.